Patents by Inventor F. Avraham Dilmanian

F. Avraham Dilmanian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7305064
    Abstract: A method of assisting recovery of an injury site of brain or spinal cord injury includes providing a therapeutic dose of X-ray radiation to the injury site through an array of parallel microplanar beams. The dose at least temporarily removes regeneration inhibitors from the irradiated regions. Substantially unirradiated cells surviving between the microplanar beams migrate to the in-beam irradiated portion and assist in recovery. The dose may be administered in dose fractions over several sessions, separated in time, using angle-variable intersecting microbeam arrays (AVIMA). Additional doses may be administered by varying the orientation of the microplanar beams. The method may be enhanced by injecting stem cells into the injury site.
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: December 4, 2007
    Assignee: Brookhaven Science Associates, LLC
    Inventors: F. Avraham Dilmanian, John W. McDonald, III
  • Patent number: 7194063
    Abstract: A method of performing radiation therapy includes delivering a therapeutic dose such as X-ray only to a target (e.g., tumor) with continuous broad beam (or in-effect continuous) using arrays of parallel planes of radiation (microbeams/microplanar beams). Microbeams spare normal tissues, and when interlaced at a tumor, form a broad-beam for tumor ablation. Bidirectional interlaced microbeam radiation therapy (BIMRT) uses two orthogonal arrays with inter-beam spacing equal to beam thickness. Multidirectional interlaced MRT (MIMRT) includes irradiations of arrays from several angles, which interleave at the target. Contrast agents, such as tungsten and gold, are administered to preferentially increase the target dose relative to the dose in normal tissue. Lighter elements, such as iodine and gadolinium, are used as scattering agents in conjunction with non-interleaving geometries of array(s) (e.g.
    Type: Grant
    Filed: February 10, 2005
    Date of Patent: March 20, 2007
    Assignee: Brookhaven Science Associates, LLC
    Inventors: F. Avraham Dilmanian, Gerard M. Morris, James F. Hainfeld
  • Patent number: 7158607
    Abstract: A method of assisting recovery of an injury site of brain or spinal cord injury includes providing a therapeutic dose of X-ray radiation to the injury site through an array of parallel microplanar beams. The dose at least temporarily removes regeneration inhibitors from the irradiated regions. Substantially unirradiated cells surviving between the microplanar beams migrate to the in-beam irradiated portion and assist in recovery. The dose may be administered in dose fractions over several sessions, separated in time, using angle-variable intersecting microbeam arrays (AVIMA). Additional doses may be administered by varying the orientation of the microplanar beams. The method may be enhanced by injecting stem cells into the injury site.
    Type: Grant
    Filed: February 10, 2005
    Date of Patent: January 2, 2007
    Assignee: Brookhaven Science Associates, LLC
    Inventors: F. Avraham Dilmanian, John W. McDonald, III
  • Patent number: 5818050
    Abstract: A method of uncollimated single photon emission computed tomography includes administering a radioisotope to a patient for producing gamma ray photons from a source inside the patient. Emissivity of the photons is measured externally of the patient with an uncollimated gamma camera at a plurality of measurement positions surrounding the patient for obtaining corresponding energy spectrums thereat. Photon emissivity at the plurality of measurement positions is predicted using an initial prediction of an image of the source. The predicted and measured photon emissivities are compared to obtain differences therebetween. Prediction and comparison is iterated by updating the image prediction until the differences are below a threshold for obtaining a final prediction of the source image.
    Type: Grant
    Filed: April 7, 1997
    Date of Patent: October 6, 1998
    Assignee: Brookhaven Science Associates LLC
    Inventors: F. Avraham Dilmanian, Randall L. Barbour
  • Patent number: 5583343
    Abstract: A nuclear medicine camera 10 and method of use photographically record radioactive decay particles emitted from a source, for example a small, previously undetectable breast cancer, inside a patient. The camera 10 includes a flexible frame 20 containing a window 22, a photographic film 24, and a scintillation screen 26, with or without a gamma-ray collimator 34. The frame 20 flexes for following the contour of the examination site on the patient, with the window 22 being disposed in substantially abutting contact with the skin of the patient for reducing the distance between the film 24 and the radiation source inside the patient. The frame 20 is removably affixed to the patient at the examination site for allowing the patient mobility to wear the frame 20 for a predetermined exposure time period. The exposure time may be several days for obtaining early qualitative detection of small malignant neoplasms.
    Type: Grant
    Filed: July 25, 1995
    Date of Patent: December 10, 1996
    Assignee: Associated Universities, Inc.
    Inventors: F. Avraham Dilmanian, Samuel Packer, Daniel N. Slatkin
  • Patent number: 5339347
    Abstract: A method of performing radiation therapy on a patient, involving exposing a target, usually a tumor, to a therapeutic dose of high energy electromagnetic radiation, preferably X-ray radiation, in the form of at least two non-overlapping microbeams of radiation, each microbeam having a width of less than about 1 millimeter. Target tissue exposed to the microbeams receives a radiation dose during the exposure that exceeds the maximum dose that such tissue can survive. Non-target tissue between the microbeams receives a dose of radiation below the threshold amount of radiation that can be survived by the tissue, and thereby permits the non-target tissue to regenerate. The microbeams may be directed at the target from one direction, or from more than one direction in which case the microbeams overlap within the target tissue enhancing the lethal effect of the irradiation while sparing the surrounding healthy tissue.
    Type: Grant
    Filed: April 27, 1993
    Date of Patent: August 16, 1994
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Daniel N. Slatkin, F. Avraham Dilmanian, Per O. Spanne
  • Patent number: 4864594
    Abstract: In-vivo bone density measuring system using a modified emission computed tomographic gamma camera arrangement for detecting radiation from two separate sources located outside of the body of the patient and oppositely disposed to the gamma camera during rotation of the gamma camera and sources means about the patient for obtaining tomographic data. The two separate sources emitting at least two energy levels. The system includes processing means for the detected radiation to provide a bone mineral density map.
    Type: Grant
    Filed: July 29, 1987
    Date of Patent: September 5, 1989
    Assignee: Elscint Ltd.
    Inventors: Dan Inbar, F. Avraham Dilmanian, Gideon Berlad